Encompass Health Corp 8-K

What Happened
Encompass Health Corporation announced its financial results for the three months ended March 31, 2026 in a press release dated April 30, 2026 and filed those results on Form 8‑K (Item 2.02). The press release (Exhibit 99.1) and supplemental earnings‑call materials (Exhibit 99.2) were attached to the filing and a cover page iXBRL file was included.

Key Details

• Press release dated April 30, 2026 reporting results for the quarter ended March 31, 2026 (Exhibit 99.1).
• Supplemental information for the company’s Q1 2026 earnings call included as Exhibit 99.2.
• Company discloses its “same‑store” comparison methodology: comparisons are based on hospitals open throughout both periods and include market consolidation transactions and capacity expansions (including satellite/remote hospitals).
• Regulation FD disclosure included; the Form 8‑K states the release is not to be deemed “filed” for certain Exchange Act and Securities Act incorporation purposes.
• Report signed by Douglas E. Coltharp, Executive Vice President and Chief Financial Officer (dated April 30, 2026).

Why It Matters
This 8‑K is the company’s formal public release of quarterly results; investors should review the attached press release and supplemental materials for the specific revenue, profit, same‑store performance and any management commentary or guidance. The disclosed same‑store methodology affects comparability to prior periods because it includes consolidation and capacity expansions. The Regulation FD note indicates the company intends the materials as current disclosure but limits automatic incorporation of the release into future filings.